Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wart-Busting patch tested in 30 people

NCT ID NCT06958237

Symptom relief Sponsor: Langsteiner sp. z o.o. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a medicated patch containing 40% salicylic acid to treat common and plantar warts. Thirty people aged 6 and older used the patch for up to 21 days. The goal was to see if the patch safely shrinks or removes warts by softening and peeling off the affected skin.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
salicylic acid (40% wart patch)
What this could lead to
If it works, this could offer a simple, at-home way to remove common and plantar warts without a doctor visit.
What could go wrong
This is a small, completed study with only 30 participants. Warts often go away on their own, so the patch may not be better than doing nothing. Skin irritation or allergy to salicylic acid is possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

May 2025

Finished

Sep 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * giving consent to participate in the clinical trial (consent of the minor's guardian where applicable); * presence of at least 1 wart (common/plantar) on the body, with a lesion up to 1 cm in diameter; * age, at least 6 years. Exclusion Criteria: * failure to meet at least 1 inclusion criterion; * the patient has a known hypersensitivity to salicylic acid, salicylates or any other component of the patch; * patients with renal impairment (renal failure); * patients with skin conditions (e.g. inflammation, wounds, eczema) at the site of application, * patients concurrently using other topical treatments in the area of the wart, * diabetic patients.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Common warts are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

common wart plantar wart

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Common warts Plantar warts

Contacts and locations

Locations

  • Dr Kowalska Clinic

    Miechów, Lesser Poland Voivodeship, 32-200, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.